-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNITYBIO SHARES UP 3.3% PREMARKET AFTER CO'S DRUG MEETS MAIN GOAL IN BLADDER CANCER TRIAL

Reuters·11/09/2026 11:42:13

Please log in to view news